Beverly A. Teicher

Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

Junko Murai, Shar-yin N. Huang, Amèlie Renaud et al. · Molecular Cancer Therapeutics · 2013 · 745 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Bioorganic Chemistry +15

Overexpression of Metallothionein Confers Resistance to Anticancer Drugs

Susan L. Kelley, Alakananda Basu, Beverly A. Teicher et al. · Science · 1988 · 604 citations

Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

Beverly A. Teicher, John S. Lazo, Alan C. Sartorelli · PubMed · 1981 · 559 citations

Chemoprevention Strategy, Pathology, Pharmacotherapy +18

Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β

Victoria C. Liu, Larry Wong, Thomas L. Jang et al. · The Journal of Immunology · 2007 · 439 citations · Full text

Cd4+cd25− T Cells, T-regulatory Cell, Immune Regulation +20

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia

Andrei V. Krivtsov, Kathryn Evans, Jayant Y. Gadrey et al. · Cancer Cell · 2019 · 421 citations · Full text

Hematological Malignancy, Chromatin, Mll-rearranged Leukemia +9